News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
245,726 Results
Type
Article (11735)
Company Profile (30)
Press Release (233961)
Multimedia
Podcasts (12)
Webinars (3)
Section
Business (76374)
Career Advice (1070)
Deals (14527)
Drug Delivery (32)
Drug Development (35262)
Employer Resources (38)
FDA (6077)
Job Trends (5825)
News (129521)
Policy (9660)
Tag
Academia (760)
Academic (1)
Accelerated approval (3)
Adcomms (14)
Allergies (66)
Alliances (10442)
ALS (54)
Alzheimer's disease (654)
Antibody-drug conjugate (ADC) (88)
Approvals (6184)
Artificial intelligence (164)
Autoimmune disease (22)
Automation (12)
Bankruptcy (97)
Best Places to Work (5209)
BIOSECURE Act (2)
Biosimilars (74)
Biotechnology (23)
Bladder cancer (81)
Brain cancer (21)
Breast cancer (287)
Cancer (1980)
Cardiovascular disease (124)
Career advice (844)
Career pathing (9)
CAR-T (95)
CDC (8)
Cell therapy (262)
Cervical cancer (21)
Clinical research (31118)
Collaboration (549)
Company closure (1)
Compensation (707)
Complete response letters (4)
COVID-19 (966)
CRISPR (32)
C-suite (139)
Cystic fibrosis (52)
Data (2113)
Depression (38)
Diabetes (200)
Diagnostics (2380)
Digital health (12)
Diversity (1)
Diversity, equity & inclusion (7)
Drug discovery (68)
Drug pricing (37)
Drug shortages (11)
Duchenne muscular dystrophy (86)
Earnings (56795)
Editorial (15)
Employer branding (5)
Employer resources (33)
Events (39723)
Executive appointments (434)
FDA (7138)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (505)
Gene editing (66)
Generative AI (9)
Gene therapy (207)
GLP-1 (426)
Government (1416)
Grass and pollen (4)
Guidances (184)
Healthcare (7367)
HIV (33)
Huntington's disease (11)
IgA nephropathy (24)
Immunology and inflammation (103)
Immuno-oncology (5)
Indications (23)
Infectious disease (1055)
Inflammatory bowel disease (77)
Inflation Reduction Act (2)
Influenza (32)
Intellectual property (43)
Interviews (193)
IPO (9292)
IRA (15)
Job creations (972)
Job search strategy (744)
Kidney cancer (11)
Labor market (29)
Layoffs (171)
Leadership (8)
Legal (1730)
Liver cancer (44)
Longevity (4)
Lung cancer (293)
Lymphoma (157)
Machine learning (4)
Management (13)
Manufacturing (178)
MASH (68)
Medical device (5223)
Medtech (5223)
Mergers & acquisitions (5773)
Metabolic disorders (505)
Multiple sclerosis (59)
NASH (9)
Neurodegenerative disease (62)
Neuropsychiatric disorders (17)
Neuroscience (1034)
NextGen: Class of 2025 (2245)
Non-profit (1482)
Now hiring (12)
Obesity (242)
Opinion (72)
Ovarian cancer (54)
Pain (61)
Pancreatic cancer (70)
Parkinson's disease (104)
Partnered (5)
Patents (115)
Patient recruitment (81)
Peanut (35)
People (9796)
Pharmaceutical (12)
Pharmacy benefit managers (5)
Phase I (8524)
Phase II (13331)
Phase III (11789)
Pipeline (1337)
Policy (43)
Postmarket research (1268)
Preclinical (2916)
Press Release (14)
Prostate cancer (102)
Psychedelics (20)
Radiopharmaceuticals (130)
Rare diseases (237)
Real estate (1155)
Recruiting (16)
Regulatory (7775)
Reports (25)
Research institute (735)
Resumes & cover letters (197)
Rett syndrome (7)
RNA editing (4)
RSV (36)
Schizophrenia (66)
Series A (74)
Series B (54)
Service/supplier (2)
Sickle cell disease (34)
Special edition (11)
Spinal muscular atrophy (55)
Sponsored (12)
Startups (802)
State (1)
Stomach cancer (6)
Supply chain (48)
Tariffs (20)
The Weekly (12)
Vaccines (378)
Venture capital (23)
Weight loss (145)
Women's health (13)
Worklife (4)
Date
Today (82)
Last 7 days (295)
Last 30 days (1061)
Last 365 days (19520)
2025 (11359)
2024 (18408)
2023 (17837)
2022 (21574)
2021 (22719)
2020 (20351)
2019 (17975)
2018 (12805)
2017 (12137)
2016 (10390)
2015 (12659)
2014 (9071)
2013 (6615)
2012 (7212)
2011 (7510)
2010 (6715)
Location
Africa (281)
Alabama (23)
Alaska (1)
Arizona (67)
Arkansas (6)
Asia (14829)
Australia (2274)
California (4882)
Canada (1282)
China (418)
Colorado (188)
Connecticut (206)
Delaware (161)
Europe (34893)
Florida (604)
Georgia (118)
Hawaii (2)
Idaho (19)
Illinois (386)
India (14)
Indiana (186)
Iowa (11)
Japan (182)
Kansas (50)
Kentucky (13)
Louisiana (10)
Maine (34)
Maryland (553)
Massachusetts (3568)
Michigan (102)
Minnesota (235)
Mississippi (2)
Missouri (50)
Montana (15)
Nebraska (5)
Nevada (52)
New Hampshire (50)
New Jersey (1281)
New Mexico (11)
New York (1204)
North Carolina (518)
North Dakota (2)
Northern California (2184)
Ohio (125)
Oklahoma (4)
Oregon (15)
Pennsylvania (879)
Puerto Rico (4)
Rhode Island (13)
South America (429)
South Carolina (12)
Southern California (1837)
Tennessee (61)
Texas (683)
United States (16569)
Utah (96)
Virginia (104)
Washington D.C. (32)
Washington State (416)
West Virginia (2)
Wisconsin (59)
245,726 Results for "4".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Approvals
Amgen Wins Expansion for Uplizna as First Drug for IgG4-Related Disease
In the Phase III MITIGATE trial, Uplizna cut IgG4-related disease flares by 87% versus placebo.
April 4, 2025
·
2 min read
·
Tristan Manalac
Press Releases
BioMarin to Host Second Quarter 2025 Financial Results Conference Call and Webcast on Monday, August 4, 2025, at 4:30pm ET
July 23, 2025
·
1 min read
Press Releases
4TEEN4 Doses First Patient in Phase 1b/2a Trial of Procizumab, a Monoclonal Antibody Targeting the Biological Driver of Shock
July 23, 2025
·
4 min read
Gene therapy
Roche Absorbs $2.4B Impairment in Overhaul of Spark Gene Therapy Unit
Roche acquired Spark Therapeutics in 2019 for $4.8 billion.
March 11, 2025
·
2 min read
·
Tristan Manalac
Press Releases
4M Therapeutics Reports Positive Results from 4MT2001 GLP Safety Studies
June 11, 2025
·
2 min read
Press Releases
Gel4Med and Spartan Medical Partner to Supply G4Derm™ Plus and Suprello™ to VA and DoD Medical Facilities Nationwide
July 2, 2025
·
1 min read
Press Releases
Prothena to Report Second Quarter 2025 Financial Results on August 4
July 28, 2025
·
1 min read
Press Releases
4DMT Announces Accelerated 4D-150 Phase 3 Development in Wet AMD and Streamlined Organization to Drive Late-Stage Execution
July 3, 2025
·
7 min read
Press Releases
4B Technologies Announces Phase 1 Trial Results for 4B03-04, a Potential First-in-Class Non-Opioid Therapy for Chronic Pain
July 18, 2025
·
3 min read
Press Releases
BioCryst to Report Second Quarter 2025 Financial Results on August 4
July 22, 2025
·
1 min read
1 of 24,573
Next
